Salmeteroli xinafoas, Fluticasoni propionas

Medicinal product name Salflumix Easyhaler 50 microgram/250 microgram/dose inhalation powder
Pharmaceutical form Inhalation powder
Strength 50 µg/250 µg/dose 
Information from the MAH on shortages Not notified
Legal status Rx Prescription (Pr.)
Package leafletMS Word document 12-04-2018
Summary of product characteristicsMS Word document 25-04-2019
ATC code R03AK06 Drugs for obstructive airway diseases

Important notice

Additional information regarding the use for persons aged 75+

If used as "DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES"
SubstanceClassComment
Salmeteroli xinafoasASuitable for older persons. Potentiates sympathomimetic effects. May cause hypokalaemia.
Fluticasoni propionasASuitable for older persons. Take into account possible systemic adverse effects. Take interactions into account.

Medicinal products (6)

Availability of medicinal product Wholesalers Package size, content Primary packaging Maximum admissible pharmacy price (€ incl. VAT) Product No. Labelling
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N1: 1 × 60
(50 µg/250 µg/dose)
Inhaler    18-0072-01 Labelling text Labelling text Sep 1, 2020
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N2: 2 × 60
(50 µg/250 µg/dose)
Inhaler    18-0072-02 Labelling text Labelling text Sep 1, 2020
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N3: 3 × 60
(50 µg/250 µg/dose)
Inhaler    18-0072-03 Labelling text Labelling text Sep 1, 2020
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N1: 1 × 60
(50 µg/250 µg/dose)
Inhaler and protective cover    18-0072-04 Labelling text Labelling text Sep 1, 2020
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N2: 2 × 60
(50 µg/250 µg/dose)
Inhaler and protective cover    18-0072-05 Labelling text Labelling text Sep 1, 2020
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N3: 3 × 60
(50 µg/250 µg/dose)
Inhaler and protective cover    18-0072-06 Labelling text Labelling text Sep 1, 2020

Registration information

Marketing authorisation No. 18-0072
Date of authorisation Apr 17, 2018
Marketing authorisation holder, country Orion Corporation, Finland